RNJ Services, INC

RNJ Services, INC was paid $7.49M by Medicaid between Jan 2018 and Dec 2024, across 106 billing codes. Its largest line is G0480, Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed — 38% of everything it billed.

Compared with peers

Next to other Clinical Medical Laboratory providers in New Jersey

Rank by total paid#32 of 122

Median peer was paid$1.29M

This provider vs. median5.8×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	38,212	$1.19M
2019	30,147	$775K
2020	53,354	$1.29M
2021	58,282	$1.20M
2022	85,566	$1.36M
2023	70,129	$1.01M
2024incomplete	55,528	$666K

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
G0480	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed	38%	32,427	22,816	$2.85M
80307	Drug test(s), presumptive, any number of drug classes; immunoassay	35%	52,612	32,398	$2.61M
U0004	2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r	6.0%	7,799	6,567	$448K
87798	Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism	2.7%	4,051	3,656	$201K
U0005	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2	1.4%	5,875	5,076	$108K
82306	Vitamin D; 25 hydroxy, includes fraction(s), if performed	1.4%	11,272	10,710	$106K
87150		1.2%	2,077	1,903	$92K
80061	Lipid panel	1.2%	18,160	17,499	$89K
86803		1.1%	4,870	4,830	$82K
86696		1.1%	3,964	3,945	$79K
80053	Comprehensive metabolic panel	<1%	20,486	19,255	$62K
86703		<1%	3,507	3,498	$59K

94 more codes

84443	Thyroid stimulating hormone (TSH)	<1%	14,495	$56K
82607		<1%	9,081	$53K
86695		<1%	3,965	$47K
87481		<1%	1,693	$38K
83036	Hemoglobin; glycosylated (A1C)	<1%	16,751	$37K
82746		<1%	8,111	$35K
86618		<1%	723	$32K
86317		<1%	3,948	$29K
85025	Blood count; complete (CBC), automated, and automated differential WBC count	<1%	22,082	$29K
84153		<1%	2,751	$29K
87389	Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies	<1%	1,500	$25K
84439		<1%	6,133	$24K
87640		<1%	3,210	$21K
87653		<1%	3,240	$21K
82550		<1%	4,955	$21K
82728		<1%	3,616	$19K
83550		<1%	6,102	$19K
87799		<1%	1,877	$16K
83540		<1%	6,417	$12K
87482		<1%	1,563	$10K
85651		<1%	7,229	$8K
U0003	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r	<1%	154	$8K
84403		<1%	230	$7K
87801	Infectious agent detection by nucleic acid; amplified probe, multiple organisms	<1%	653	$7K
86706		<1%	586	$7K
87340		<1%	585	$6K
87500		<1%	1,144	$6K
86141		<1%	676	$6K
84270		<1%	212	$5K
84154		<1%	283	$5K
86708		<1%	423	$5K
81001		<1%	11,362	$4K
82627		<1%	152	$4K
82533		<1%	250	$4K
P9603	Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated miles actually travelled	<1%	3,320	$3K
82670		<1%	137	$3K
83525		<1%	275	$3K
87633	Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets	<1%	160	$3K
P9604	Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated trip charge	<1%	10,673	$3K
87086	Culture, bacterial; quantitative colony count, urine	<1%	4,205	$3K
84144		<1%	140	$3K
84146		<1%	127	$2K
80050	General health panel	<1%	61	$2K
83001		<1%	129	$2K
83002		<1%	127	$2K
83735		<1%	2,768	$2K
87186		<1%	1,754	$2K
83880		<1%	1,587	$2K
87077		<1%	1,839	$2K
84550		<1%	1,901	$1K
83655		<1%	162	$1K
87505		<1%	15	$1K
87581		<1%	532	$1K
G2024	Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]) from an individual in a snf or by a laboratory on behalf of a hha, any specimen source	<1%	565	$1K
86769		<1%	119	$1K
80048	Basic metabolic panel (calcium, ionized)	<1%	3,968	$961.51
84480		<1%	783	$836.67
87486		<1%	535	$807.98
87502	Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets	<1%	397	$790.16
G0471	Collection of venous blood by venipuncture or urine sample by catheterization from an individual in a skilled nursing facility (snf) or by a laboratory on behalf of a home health agency (hha)	<1%	21,290	$758.20
87522	Neg quan hep c or qual rna	<1%	45	$740.00
87635	Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe	<1%	150	$605.62
87634		<1%	399	$579.02
84481		<1%	1,043	$555.94
87631		<1%	244	$453.71
87651	Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe	<1%	15	$418.00
86038		<1%	55	$413.40
80076		<1%	2,135	$360.79
83825		<1%	42	$352.80
36415	Collection of venous blood by venipuncture	<1%	1,850	$326.18
82043		<1%	1,895	$325.53
87498		<1%	386	$318.79
86431		<1%	67	$292.50
G2023	Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source	<1%	20	$281.52
87503		<1%	396	$242.63
86592		<1%	96	$217.14
82570		<1%	1,900	$200.17
83090		<1%	50	$182.83
85610		<1%	2,870	$150.87
82330		<1%	15	$138.15
84436		<1%	598	$131.86
84100		<1%	531	$128.74
82248		<1%	911	$121.06
85027		<1%	1,995	$112.20
86709		<1%	424	$99.20
86140		<1%	1,263	$89.78
81003		<1%	475	$44.70
82040		<1%	13	$23.40
84134		<1%	15	$11.67
82150		<1%	152	$9.00
83690		<1%	138	$9.00
85045		<1%	87	$6.00
84479		<1%	43	$1.29
80164		0%	79	$0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialWARKENTIN, DONALD (MEDICAL DIRECTOR)